S
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Price:
68.49
CNY
4.47%
Market Closed
Market Cap:
¥42.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
Shenzhen Yinghe Technology Co Ltd
SZSE:300457
|
CN |
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
|
A
|
Asce Gayrimenkul Yatirim Ortakligi AS
IST:ASGYO.E
|
TR |
|
Asbury Automotive Group Inc
NYSE:ABG
|
US |
|
Trimegah Sekuritas Indonesia Tbk PT
IDX:TRIM
|
ID |
|
Meridia Real Estate III Socimi SA
MAD:YMRE
|
ES |
|
S
|
Sung Kwang Bend Co Ltd
KOSDAQ:014620
|
KR |
|
Comefly Outdoor Co Ltd
SSE:603908
|
CN |
Relative Value
The Relative Value of one Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 68.49 CNY, Sunshine Guojian Pharmaceutical Shanghai Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
42.3B CNY | 34.1 | 55.2 | 161.8 | 161.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 6 | 87.4 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.2 | 24.8 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.7 | 29.5 | 22.2 | 23.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13 | 14.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
